✦ LIBER ✦

A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C

✍ Scribed by Pham Thi Thu Thuy; Chalermrat Bunchorntavakul; Ho Tan Dat; K. Rajender Reddy

Book ID: 116652693
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 852 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2011.12.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic hepatitis C genotype 6 responds

Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1

✍ Owen T-Y Tsang; Jonpaul S-T Zee; Jacky M-C Chan; Reggie S-T Li; Yee-Man Kan; Fra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Randomized controlled trial of pegylated

Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6

✍ Khoa D. Lam; Huy N. Trinh; Son T. Do; Thuan T. Nguyen; Ruel T. Garcia; Tuan Nguy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 2 views

Hepatitis C virus (HCV) genotype is an important criteria in determining duration of therapy and predictor of sustained virologic response (SVR) to pegylated interferon (PEG IFN) and ribavirin (RBV) therapy. Optimal duration of therapy for patients with HCV genotype 6 is not known. We conducted a mu

Nitazoxanide plus pegylated interferon a

Nitazoxanide plus pegylated interferon and ribavirin in the treatment of genotype 4 chronic hepatitis C, a randomized controlled trial

✍ Shehab, Hany M.; Elbaz, Tamer M.; Deraz, Dalia M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Effect of vitamin D supplementation on p

Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial

✍ Yokoyama, S.; Takahashi, S.; Kawakami, Y.; Hayes, C. N.; Kohno, H.; Kohno, H.; T 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

314 Randomized Controlled Trial of Pegyl

314 Randomized Controlled Trial of Pegylated Interferon-Alpha 2a and Ribavirin in Patients With Treatment-NaïVE Chronic Hepatitis C Genotype 6

✍ Lam, Khoa D.; Trinh, Huy N.; Do, Son T.; Nguyen, Thuan T.; Garcia, Ruel T.; Nguy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 91 KB

An open-label randomized controlled stud

An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin

✍ C. Kondo; M. Atsukawa; A. Tsubota; N. Itokawa; T. Fukuda; Y. Matsushita; H. Kido 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB